Compositions and methods for diagnosis and treatment of neurodegenerative diseases
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease are inadequate, as they fail to effectively address contributors like peripheral and central inflammation, amyloid-β plaque deposition, neuronal iron deposition, and hyperglycemia, which are key factors in disease progression.
Innovation Solution
Compositions comprising small molecule biochemicals and their derivatives, administered in specific dosages, are used to modulate markers of neurodegenerative diseases, including increasing serum concentrations of biochemicals like hippurate and phosphatidylcholine to treat and prevent these conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for neurodegenerative diseases are used, then existing therapeutic approaches are maintained, but they fail to effectively address key contributors like inflammation, amyloid-β plaque deposition, neuronal iron deposition, and hyperglycemia
Solution Approach 1:
The treatment approach is segmented into multiple targeted interventions, each addressing a specific contributor to neurodegenerative diseases. The composition includes distinct components that separately target inflammation, amyloid-β plaques, iron deposition, and hyperglycemia, allowing each component to specialize in modulating its specific marker without interfering with other therapeutic mechanisms.
Solution Approach 2:
The invention changes the therapeutic parameters by using small molecule biochemicals that specifically modulate biomarkers associated with disease contributors. By altering the chemical parameters of treatment—using metabolites and biochemicals that can cross the blood-brain barrier and directly influence pathological processes—the therapy achieves greater effectiveness in addressing the root causes of neurodegeneration.
2Reliability
If small molecule biochemicals are administered to modulate disease markers, then treatment effectiveness is improved, but the complexity of the treatment regimen increases
Solution Approach 1:
The small molecule biochemicals in the composition are designed with multi-functionality, capable of modulating multiple disease markers simultaneously. A single biochemical can influence inflammation, amyloid-β metabolism, and iron regulation through different molecular mechanisms, reducing the need for multiple separate treatments and simplifying the overall regimen while maintaining comprehensive disease marker modulation.
Solution Approach 2:
The treatment leverages the body's own metabolic pathways and natural biochemical processes. By administering small molecule biochemicals that work through endogenous mechanisms—such as utilizing existing metabolic enzymes and transport systems—the therapy achieves disease marker modulation through the body's self-service capabilities, reducing the need for complex external intervention systems.
3Ease of operation
If blood-based biomarkers are used for detection, then diagnostic accessibility is improved, but the precision of detecting central nervous system conditions may be compromised
Solution Approach 1:
The invention uses small molecule biochemicals as intermediaries that can cross the blood-brain barrier and reflect central nervous system pathology in peripheral blood. These biochemicals serve as mediators, carrying information about CNS conditions (such as inflammation, amyloid-β metabolism, and iron status) from the brain to the bloodstream, where they can be detected with high precision using accessible blood-based assays.
Solution Approach 2:
The detection method changes the measurement parameters by focusing on specific small molecule biochemicals and their metabolic profiles in blood. Rather than measuring general markers, the invention quantifies specific biochemical parameters—such as metabolite ratios, concentration thresholds, and metabolic pathway signatures—that provide high-precision information about CNS conditions through accessible blood samples.
Data Source
AI summary
Compositions including small molecule biochemicals, and salts and derivatives thereof, and methods for detection, treatment or prophylaxis of neurodegenerative diseases are provided, including compositions and methods for detecting and treating conditions that contribute to neurodegenerative diseases, including peripheral and central inflammation, amyloid-β plaque deposition in the brain, neuronal iron deposition and hyperglycemia.